US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Yesterday's Top Gainers

788.15

-8.2339-1.03%

Number of Gainers:19

Number of Losers:35

Number of Flat:3

PE:- -

High:799.76

Open:796.41

Low:786.92

Close:796.41

Loading ...

Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges

RLX Technology to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025

We Think EDU Holdings' (ASX:EDU) Profit Is Only A Baseline For What They Can Achieve

Simply Wall St.

PEDEVCO Announces Entry into Joint Development Agreement with Large Private Equity-Backed D-J Basin E&P Company

ACCESS Newswire

New Mechanical Problems Plague Boeing’s (NYSE:BA) KC-46A

Li Auto (NasdaqGS:LI) Surges 35% with 30% Jump in February Deliveries

Simply Wall St.

RELX PLC Acquires Additional Treasury Shares

March 2025 Penny Stocks To Consider For Growth

Simply Wall St.

Ocugen's Gene Therapies Receive EMA Advanced Therapy Classification for Vision Loss Treatment

MT Newswires Live

BRIEF-Ocugen Announces Positive Opinion Of EMA’S Committee For Advanced Therapies For ATMP Classification

Unusually active option classes on open March 3rd

Ocugen Announces Positive Opinion of Ema’s Committee for Advanced Therapies for Atmp Classification for Novel Modifier Gene Therapy Candidate Ocu410 for Geographic Atrophy and Ocu410st for Stargardt Disease

THOMSON REUTERS

Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease

Acurx Announces Publication of Nonclinical in Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects From Other Anti-Cdi Antibiotics

THOMSON REUTERS

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Mitsubishi Electric Automotive America Signs Agreement with Seeing Machines to Promote Guardian Generation 3 Driver Monitoring Technology Across the Americas

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4563/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4563"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","market":"US","secType":"PLATE","nameCN":"Yesterday's Top Gainers","latestPrice":788.1786,"timestamp":1741282340194,"preClose":796.41254,"halted":0,"volume":47686086,"delay":0,"changeRate":-0.010339,"change":-8.233948,"pbRate":2.308958,"amount":629368009.04731,"amplitude":0.016123,"prevYearClose":733.5465,"fiveDayClose":799.0119,"twentyDayClose":723.8612,"turnoverRate":0.008613,"marketCap":142531037553,"floatMarketCap":81336291347,"peRate":57.205386},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","high":799.75653,"amplitude":0.016123,"preClose":796.41254,"low":786.9159,"pbRate":"2.308958","latestPrice":788.1452,"volume":47684138,"delay":0,"open":796.4098,"prevYearClose":733.5465,"prevWeekClose":790.6026,"prevMonthClose":790.6026,"prevQuarterClose":733.5465,"fiveDayClose":799.0119,"twentyDayClose":723.8612,"sixtyDayClose":736.6684,"secType":"PLATE","market":"US","turnoverRate":0.008613,"peRate":57.205386,"marketCap":142531037553,"floatMarketCap":81336291347,"timestamp":1741282339127,"nameCN":"Yesterday's Top Gainers"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4563\",,,,undefined,":{"bkCode":"BK4563","up":19,"down":35,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4563\",pageSize:16,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516617757","title":"Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2516617757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516617757?lang=en_us&edition=fundamental","pubTime":"2025-03-04 14:01","pubTimestamp":1741068112,"startTime":"0","endTime":"0","summary":"Mersana Therapeutics (MRSN) has disclosed a new risk, in the Accounting & Financial Operations category. Mersana Therapeutics faces significant bus...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mersana-therapeutics-viability-in-question-amidst-persistent-financial-losses-and-funding-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mersana-therapeutics-viability-in-question-amidst-persistent-financial-losses-and-funding-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","MRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2516154696","title":"RLX Technology to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516154696","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516154696?lang=en_us&edition=fundamental","pubTime":"2025-03-04 11:30","pubTimestamp":1741059000,"startTime":"0","endTime":"0","summary":"- Earnings Call Scheduled for 8:00 a.m. ET onMarch14, 2025 -. SHENZHEN, China, March 3, 2025 /PRNewswire/ -- RLX Technology Inc.  , a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before the U.S. markets open on Friday, March 14, 2025.The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 14, 2025 .Dial-in details for the earnings conference call are as follows:. Participants should dial-in 10 minutes before the scheduled start time and ask to be connected to the call for \"RLX Technology Inc.\" with the Participant Code as set forth above.A replay of the conference call will be accessible approximately two hours after the conclusion of the call until March 21, 2025, by dialing the following telephone numbers:. RLX Technology Inc.  is a leading global branded e-vapor company. The Company leverages its strong in-house t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/rlx-technology-report-fourth-quarter-033000720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rlx-technology-report-fourth-quarter-033000720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4551","RLX","BK4075","BK4526"],"gpt_icon":0},{"id":"2516643115","title":"We Think EDU Holdings' (ASX:EDU) Profit Is Only A Baseline For What They Can Achieve","url":"https://stock-news.laohu8.com/highlight/detail?id=2516643115","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516643115?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:09","pubTimestamp":1741050595,"startTime":"0","endTime":"0","summary":"When companies post strong earnings, the stock generally performs well, just like EDU Holdings Limited's ( ASX:EDU...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-edu/edu-holdings-shares/news/we-think-edu-holdings-asxedu-profit-is-only-a-baseline-for-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4503","LU0327786744.USD","BK4510","LU0455707207.USD","BK7132","BK4505","BK4204","LU0370786039.SGD","BK4211","BK4585","LU0359202008.SGD","BK4563","BK4535","LU0572944931.SGD","LU0048580855.USD","BK4526","BK4506","BK4531","LU0359201612.USD","LU0823426480.USD","LU1023057109.AUD","BK4588","LU0823426308.USD","LU0502904849.HKD","EDU.AU","FCF","BK4509","LU2242644610.SGD"],"gpt_icon":0},{"id":"2516366132","title":"PEDEVCO Announces Entry into Joint Development Agreement with Large Private Equity-Backed D-J Basin E&P Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2516366132","media":"ACCESS Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516366132?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:30","pubTimestamp":1741037400,"startTime":"0","endTime":"0","summary":"HOUSTON, TX / ACCESS Newswire / March 3, 2025 / PEDEVCO Corp.   today announced that it has entered into a joint development agreement  with a large, Denver, Colorado-based private equity-backed D-J Basin E&P Company with extensive operational experience , pursuant to which the companies have agreed to jointly participate in the expansion and development of the Company's Roth and Amber DSUs located in Weld County, Colorado. Pursuant to the Agreement, in exchange for the Operator's payment to the Company of approximately $1.7 million, the Company agreed to submit to the Colorado Energy and Carbon Management Commission  spacing applications to amend the Company's existing Roth and Amber DSUs to increase each of their sizes from ~1,280 acres to ~1,600 acres, transfer operatorship of the DSUs to the Operator, and jointly participate in the development of the Roth DSU with each party having not less than a 40% working interest. The parties further agreed that the Operator shall commence the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pedevco-announces-entry-joint-development-213000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4213","BK4585","BK4588","BK4185","PED","JYNT","EQR","BK4215"],"gpt_icon":0},{"id":"2516865060","title":"New Mechanical Problems Plague Boeing’s (NYSE:BA) KC-46A","url":"https://stock-news.laohu8.com/highlight/detail?id=2516865060","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516865060?lang=en_us&edition=fundamental","pubTime":"2025-03-04 03:33","pubTimestamp":1741030396,"startTime":"0","endTime":"0","summary":"There are those who might have thought aerospace stock Boeing ($BA) was back on track after months of disasters and setbacks. Sadly, those folks we...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/new-mechanical-problems-plague-boeings-nyseba-kc-46a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/new-mechanical-problems-plague-boeings-nyseba-kc-46a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","BK4607","LU1435385759.SGD","BA","BK4608","LU1429558221.USD","BK4585","BK4116","BK4551","BK4588","LU2326559502.SGD","BK4563","BK4564","BK4187","BK4526","NYSE"],"gpt_icon":0},{"id":"2516540276","title":"Li Auto (NasdaqGS:LI) Surges 35% with 30% Jump in February Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540276","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516540276?lang=en_us&edition=fundamental","pubTime":"2025-03-04 02:04","pubTimestamp":1741025097,"startTime":"0","endTime":"0","summary":"Li Auto posted an impressive 35% price increase in the last quarter, coinciding with a robust delivery growth reported in early 2025. The announcement on March 1, revealing a 29.7% increase in year-over-year vehicle deliveries for February totaling 26,263, spotlighted the company's accelerating momentum, which continued strong delivery numbers from January with nearly 30,000 vehicles. As the broader market grappled with 1.3% downturns amid economic uncertainties, Li Auto differentiated itself through consistent delivery growth, defying the trend impacting major indices like the Nasdaq, which faced a 4% decline in February. This contrast, set against a backdrop of concerns over trade policies and tariffs affecting other industries, underscores the resilience and expansion of the electric vehicle sector. The price uptick reflects positive investor sentiment, driven by Li Auto's performance and growth aspirations as it expands its market presence.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/li-auto-nasdaqgs-li-surges-180457502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Li Auto (NasdaqGS:LI) Surges 35% with 30% Jump in February Deliveries","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BK4588","BK4099","BK4585","BK4526","BK4548","EVS.SI","LI","BK4555","BK4563","BK4503"],"gpt_icon":1},{"id":"2516024659","title":"RELX PLC Acquires Additional Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2516024659","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516024659?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:28","pubTimestamp":1741022881,"startTime":"0","endTime":"0","summary":"RELX plc ( ($GB:REL) ) has provided an announcement. RELX PLC announced the purchase of 255,385 of its own ordinary shares through UBS AG London Br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/relx-plc-acquires-additional-treasury-shares-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/relx-plc-acquires-additional-treasury-shares-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US2Y.BOND","RLX","US5Y.BOND","US30Y.BOND","US3Y.BOND","US7Y.BOND","BK4526","BK4563","US6M.BOND","BK4075","US10Y.BOND","US12M.BOND","BK4551"],"gpt_icon":0},{"id":"2516656760","title":"March 2025 Penny Stocks To Consider For Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656760","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656760?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:04","pubTimestamp":1741021496,"startTime":"0","endTime":"0","summary":"As the U.S. stock market grapples with economic uncertainties and fluctuating indices, investors are increasingly exploring diverse opportunities for growth. Penny stocks, often associated with smaller or newer companies, continue to capture interest due to their potential for significant returns at lower price points. Despite being considered a somewhat outdated term, these stocks can offer substantial growth prospects when backed by solid financials and strong fundamentals.Overview: Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on the research, development, and commercialization of Alpha DaRT for treating solid cancer in Israel and the United States, with a market cap of $211.71 million.Overview: Wrap Technologies, Inc. is a public safety technology and services company that develops policing solutions for law enforcement and security personnel globally, with a market cap of $100.48 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/march-2025-penny-stocks-consider-170456976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TTI","BK4179","BABB","BK4209","DRTS","DRTSW","PHX","SGHT","BK4539","WRAP","BK4213","BK4563","BK4082","PVL","SB","BK4021"],"gpt_icon":0},{"id":"2516653170","title":"Ocugen's Gene Therapies Receive EMA Advanced Therapy Classification for Vision Loss Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653170","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516653170?lang=en_us&edition=fundamental","pubTime":"2025-03-04 00:22","pubTimestamp":1741018934,"startTime":"0","endTime":"0","summary":"Ocugen  said Monday that the European Medicines Agency's Committee for Advanced Therapies issued a positive opinion granting Advanced Therapy Medicinal Product classification for its OCU410 and OCU410ST gene therapy candidates, which are being developed to treat vision loss caused by geographic atrophy and Stargardt disease.Dosing in the Phase 2 portion of the OCU410 clinical trial has been completed, and Ocugen expects to begin a Phase 3 trial next year, with plans to pursue regulatory approval in the US and Europe in 2028.Last week, the US Food and Drug Administration endorsed Ocugen's plan to initiate a Phase 2/3 pivotal confirmatory trial for OCU410ST, which could support future biologics license and marketing authorization applications in the US and EU, respectively.If approved, OCU410 could become the first treatment available in Europe for geographic atrophy, a late-stage form of dry age-related macular degeneration. While two therapies are currently approved in the US, neither ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z4B17.USD","AEIS","BK4157","OCGN","BK4568","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK6522","BK4139","BLZ.SI","BK4563","BK6088","IE0031619046.USD"],"gpt_icon":0},{"id":"2516329226","title":"BRIEF-Ocugen Announces Positive Opinion Of EMA’S Committee For Advanced Therapies For ATMP Classification","url":"https://stock-news.laohu8.com/highlight/detail?id=2516329226","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516329226?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:53","pubTimestamp":1741013593,"startTime":"0","endTime":"0","summary":"BRIEF-Ocugen Announces Positive Opinion Of EMA’S Committee For Advanced Therapies For ATMP Classification March 3 (Reuters) - Ocugen Inc OCGN.O:OCUGEN ANNOUNCES POSITIVE OPINION OF EMA’S COMMITTEE FOR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN","BK4563","BK4139","BK4568"],"gpt_icon":0},{"id":"2516605632","title":"Unusually active option classes on open March 3rd","url":"https://stock-news.laohu8.com/highlight/detail?id=2516605632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516605632?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:40","pubTimestamp":1741012844,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Vodafone (VOD), Allegro MicroSystems (ALGM), Canaan Inc (CAN), Li Auto (LI), Mosaic (MOS), Hut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-march-3rd-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-march-3rd-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4099","LU2380233275.USD","MOS","LU0353189763.USD","BK4132","BK4585","BK4600","BK4595","CAN","VOD","LU0053671581.USD","BK4093","BK4526","LI","EVS.SI","BK4141","BK4503","BK4555","BK4563","ALGM","BK4532","BK4588","BK4551","BK4548","LU2087625088.SGD","LU0353189680.USD","BK4170"],"gpt_icon":0},{"id":"2516639628","title":"Ocugen Announces Positive Opinion of Ema’s Committee for Advanced Therapies for Atmp Classification for Novel Modifier Gene Therapy Candidate Ocu410 for Geographic Atrophy and Ocu410st for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516639628?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2516112639","title":"Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2516112639","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516112639?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010400,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., March 03, 2025  -- Ocugen, Inc.  , a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the European Commission has provided a positive opinion from the European Medicines Agency’s  Committee for Advanced Therapies  for OCU410 and OCU410ST Advanced Therapy Medicinal Product  classification. OCU410 is a novel, multifunctional modifier gene therapy candidate being developed for the treatment of patients with vision loss due to geographic atrophy —an advanced stage of dry age-related macular degeneration —and OCU410ST is being developed for Stargardt disease due to ABCA4-related retinopathies.GA affects 2-3 million people in the United States  and Europe combined. There are two approved therapies in the U.S. that require frequent dosing , however neither therapy has been approved in Europe. Stargardt disease affects 100,000 people in the U.S. and Europe combined, and there are no approved treatments available globally.6-month data ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocugen-announces-positive-opinion-ema-140000451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","LU1988902786.USD","BK4588","IE00B66KJ199.SGD","OCGN","BK4568","LU2106854487.HKD","LU0942090050.USD","LU0868494708.USD","BK4516","LU2237438978.USD","IE00B19Z4B17.USD","MAA","IE00BD6J9T35.USD","LU2023250504.SGD","AEIS","LU1974910355.USD","BK4149","LU1064131342.USD","CAT","BK4139","LU1917777945.USD","LU0868494617.USD","IE00B7SZL793.SGD","IE0031619046.USD","BK4597","LU2264538146.SGD","IE00BSNM7G36.USD","BK4157","BK4563","ATMP","BK4532","BK4585","BK4520"],"gpt_icon":0},{"id":"2516633675","title":"Acurx Announces Publication of Nonclinical in Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects From Other Anti-Cdi Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633675?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006829,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NS76Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2516635992","title":"Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635992","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635992?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat  to other anti-CDI antibiotics in a germ-free mouse model. Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced compared to those observed in vancomycin -or metronidazole -treated groups, complementing prior Phase 2 clinical findings showing IBZ's more selective antibacterial activity. Notable differences were observed between the microbiome of IBZ- and fidaxomicin -treated groups, which may allow for differentiation of these two anti-CDI antibiotics in future studies. Results establish IBZ differentiating effects on the gut microbiome, indicating a more selective spectrum of microbiome alteration compared to broader-spectrum antibiotics like VAN and MET and a narrower spectrum of microbiome alteration compared to FDX. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-nonclinical-vivo-130000861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MET","LU1989772923.USD","BK4588","LU1571399168.USD","BK4539","BK4139","LU1989772840.SGD","LU0310800965.SGD","BK4202","ACXP","NCI","LU0742534661.SGD","BK4533","BK4162","PK","GAIN","LU0052756011.USD","LU1496350502.SGD","LU1267930227.SGD","LU0251131958.USD","LU1291159041.SGD","ECC","BK4135","BK4585","BK4218","BK4131","BK4563","LU0128525689.USD","BK4181","LU1989771016.USD","BK4215","VRE","IDSA","BK4194","MAA","LU0251142724.SGD","LU0048573561.USD","FDX"],"gpt_icon":0},{"id":"2516633492","title":"Mitsubishi Electric Automotive America Signs Agreement with Seeing Machines to Promote Guardian Generation 3 Driver Monitoring Technology Across the Americas","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633492","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633492?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"Mitsubishi Electric Automotive America, Inc.  and Seeing Machines Limited representatives. MEAA has signed a Referral Agreement with Seeing Machines Limited to promote Seeing Machines’ Guardian Generation 3 driver monitoring solution across the Americas. . Guardian Generation 3 aftermarket system uses advanced computer monitoring technology to track signs of driver distraction and drowsiness. MASON, Ohio, March 03, 2025----Mitsubishi Electric Automotive America, Inc. , a leader in advanced automotive electrical and electronic systems, today announced it has signed a Referral Agreement with Seeing Machines Limited to promote Seeing Machines’ Guardian Generation 3 driver monitoring solution across the Americas.Following Mitsubishi Electric Mobility Corporation’s strategic investment in Seeing Machines in December 2024, this agreement leverages MEAA’s extensive aftermarket distribution network and customer relationships in the transport and logistics industries.Guardian Generation 3 will ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mitsubishi-electric-automotive-america-signs-130000356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4168","MIELY","BK4009","DMS","TMC","MIELF","BK4182"],"gpt_icon":0}],"pageSize":16,"totalPage":21,"pageCount":6,"totalSize":331}]}}